Page 11 - Patrick Riley News Today

Blast Radio, the free audio platform for listeners to hear studio-quality broadcasts directly from the artists they love, daily, is expanding their product line beyond hardware to include a software plugin that allows artists to broadcast to the platform directly from their digital audio workstation (DAW).   To celebrate the launch, Blast Radio is announcing exclusive broadcasts from artists including Alex Cameron, Animal Collective, Kevin Morby, Roy Molloy, and more.

Pictured: K-9 Zoa. Photo courtesy of the Calhoun County Sheriff's Office. The Calhoun County Sheriff's Office reports their newest K-9 officer, Zoa, died Friday

Provincetown, Truro schools require masks indoors; plan COVID tests

The movie was independently financed with people from Minnesota, filmed in Minnesota and features a cast and crew mostly from Minnesota.

/PRNewswire/ -- Community oncology practices are continuing to adapt to value-based reimbursement models as the Centers for Medicare and Medicaid Services...

Government to channel investments toward procuring qualified platforms that embrace multiple customers and stakeholders, finds Frost & Sullivan SANTA CLARA,

Adopting Cloud Platforms will Improve Federal Healthcare Agency Interoperability and Customer Experience, from Frost & Sullivan.

/PRNewswire/ -- Payment integrity solutions are evolving in terms of technology, strategy, and services for higher claim accuracy. As administrative and...

Former Bristol Myers Squibb compatriots are reuniting at Flagship Pioneering. Natural killer cell biotech Acepodia has enlisted AbbVie oncology exec Thorsten Graef as its chief medical officer. And Centessa has called upon a former AstraZeneca heavyweight as its new CMO.

Published: May 13, 2021 By Alex Keown Akouos, Inc. – Kathy Reape was named chief development officer of Boston-based Akouos. Reape most recently served as chief medical officer at Spark Therapeutics where she oversaw clinical development, pharmacovigilance, and medical affairs activities. Reape was a key member of the team responsible for the development and commercialization of Luxturna, the first FDA-approved in vivo gene therapy approved for an inherited retinal disease caused by m...